These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4147117)

  • 1. Comparison of two cardioselective beta-adrenergic blocking agents: effects on haemodynamic and atrioventricular conduction in man.
    Crouchman M
    Br Heart J; 1973 Aug; 35(8):865. PubMed ID: 4147117
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of haemodynamic effects of oxprenolol (trasicor), alprenolol (aptin), and sotalol (MJ 1999) in man.
    Gibson DG; Hoy J; Sowton E
    Br Heart J; 1970 Jul; 32(4):553. PubMed ID: 4393535
    [No Abstract]   [Full Text] [Related]  

  • 3. Isoproterenol blockade in man; comparison between penbutalol and acebutolol.
    Coleman AJ; Leary WP; Asmal AC
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):64-79. PubMed ID: 4149207
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.
    Coleman AJ; Leary WP
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):673-8. PubMed ID: 4404477
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemodynamic effects of a new beta-blocking agent 'Sectral' (M & B 17803A).
    Lewis BS; Bakst A; Mitha AS; Purdon K; Gotsman MS
    Br Heart J; 1973 Jul; 35(7):743-51. PubMed ID: 4146280
    [No Abstract]   [Full Text] [Related]  

  • 6. The selective beta receptor blocking properties of DL-1-(2-acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane HC1 (M & B 17803-A) in the anesthetized dog.
    Levy B
    J Pharmacol Exp Ther; 1973 Jul; 186(1):134-44. PubMed ID: 4146701
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular effects of dl-1-(2-acetyl-4-butyramido-phenoxy)-2-hydroxy-3-isopropylaminopropane (M & B 17,803A), a new cardioselective beta adrenoreceptor blocking agent.
    Laddu AR
    Jpn Heart J; 1974 Jan; 15(1):72-83. PubMed ID: 4151910
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of relative actions of beta-adrenergic blocking drugs on heart rate and left ventricular ejection using a non-invasive method in patients with aortic Starr-Edwards prostheses.
    Crouchman MR
    Br Heart J; 1973 May; 35(5):475-9. PubMed ID: 4146054
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the combined use of beta-adrenergic blockade and antiarrhythmic drugs.
    Mazurowa A; Szadowska A; Szmigielski A; Litwinowicz A
    Arch Immunol Ther Exp (Warsz); 1970; 18(2):280-7. PubMed ID: 4393014
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Preliminary studies of Ro 3-3528, a beta-adrenoceptor-blocking agent, in man.
    Hicks DC; Phillips EM
    Br J Pharmacol; 1972 Feb; 44(2):377P-378P. PubMed ID: 4148922
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects on the hemodynamics and myocardial contractility of 2 beta blockader agents: propranolol and proctolol].
    Sanguinetti M; Picchio FM; Maresta A; Branzi A; Baccarani G; Binetti G
    G Ital Cardiol; 1972; 2(5):710-9. PubMed ID: 4404053
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
    Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
    [No Abstract]   [Full Text] [Related]  

  • 13. Adrenergic antagonists, and a possible link between the increase in cyclic adenosine 3',5'-monophosphate and DNA synthesis during liver regeneration.
    MacManus JP; Braceland BM; Youdale T; Whitfield JF
    J Cell Physiol; 1973 Oct; 82(2):157-64. PubMed ID: 4148138
    [No Abstract]   [Full Text] [Related]  

  • 14. Antagonism of cardiac arrhythmias by dl-1-(2-acetyl-4-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane (M & B 17,803A), a new beta adrenoreceptor blocking agent.
    Laddu AR
    Jpn Heart J; 1974 Jan; 15(1):61-71. PubMed ID: 4151909
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic studies on the beta receptor blockader Kö 592 under rest and under exertion].
    Deibert K; Steim H; Heinrich K; Siller K
    Med Klin; 1972 Jun; 67(24):845-9. PubMed ID: 4403610
    [No Abstract]   [Full Text] [Related]  

  • 16. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
    Szekeres L; Udvary E; Papp JG
    Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
    [No Abstract]   [Full Text] [Related]  

  • 17. [Electrophysiological effects of beta-blockaders in man].
    Benaïm B; Chapelle M
    Nouv Presse Med; 1978 Sep; 7(31):2697-701. PubMed ID: 30945
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic studies with sotalol in man, performed at rest, during exercise, and during right ventricular pacing.
    Thumala A; Hammermeister KE; Campbell WB; Pomerantz B; Overy H; Davies H
    Am Heart J; 1971 Oct; 82(4):439-47. PubMed ID: 4398733
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of immediate haemodynamic effects of three beta-adrenergic blocking agents.
    Rivier JL; Nissiotis E; Jaeger M
    Postgrad Med J; 1970 Nov; ():Suppl:44-9. PubMed ID: 4395457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.